Curriculum Vitae
Neal R. Chamberlain
ADDRESS:
A. T. Still University of Health Sciences/Kirksville College of Osteopathic Medicine,
Department of Microbiology/Immunology,
800 West Jefferson Street,
Kirksville, MO. 63501
BIRTH DATE: Sept. 2, 1958
EDUCATION:
B.S., Biology, Indiana University of Pennsylvania, Indiana, Pennsylvania, 9/76-6/80.
Ph.D., Medical Microbiology and Immunology, Ohio State University, 9/80-8/85. Dissertation: The Presence of Delta Toxin and Lipase in Murine Intraperitoneal Abscesses Generated by Staphylococcus aureus. Major Professor: Dr. Frank A. Kapral.
Postdoctoral Fellowship, University of Texas Southwestern Medical School in Dallas, Microbiology Department, 9/85-4/89, Mentor: Dr. Michael V. Norgard.
CURRENT POSITION:
Associate Professor, Department of Microbiology/Immunology, A. T. Still University of Health Sciences/Kirksville College of Osteopathic Medicine, Kirksville, Missouri, 3/89 to present.
PAST PROFESSIONAL ACTIVITIES:
Postdoctoral Fellow, Department of Microbiology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas. 7/85-2/89. Supervisor: Dr. Michael V. Norgard.
Laboratory Instructor, University of Texas Southwestern Medical Center at Dallas; 9/85-11/87; Leader of medical student small group discussions involving various problems and concepts in medical microbiology.
Research Associate, Ohio State University, dissertation research; 9/80-6/85; research on delta toxin and lipase in murine abscesses.
Teaching Associate, OSU, Department of Medical Microbiology and Immunology; 6/85-3/85; Lab instructor for infectious diseases and medical microbiology (course in independent study program under direction of Dr. Ottolenghi).
Teaching Assistant, OSU, Department of Medical Microbiology and Immunology; 9/81-8/84; Assisting and preparing for medical microbiology lab for medical students.
SOCIETIES:
Member - American Society for Microbiology
Fellow from 2009 to 2013- National Academy of Osteopathic Medical Educators (NAOME) created by the American Association of Colleges of Osteopathic Medicine (AACOM) in 2008.
PUBLICATIONS:
1. M.V. Norgard, N.R. Chamberlain, M.A. Swancutt, and M.S. Goldberg. 1986. Cloning and Expression of the Major 47-Kilodalton Surface Immunogen of Treponema pallidum in Escherichia coli. Infect. Immun. 42: 435-445.
2. N.R. Chamberlain, J.D. Radolf, P.L. Hsu, S. Sell, and M.V. Norgard. 1988. Genetic and Physicochemical Characterization of the Recombinant DNA-derived 47-Kilodalton Surface Immunogen of Treponema pallidum subsp. pallidum. Infect. Immun. 56 71-78.
3. J.D. Radolf, N.R. Chamberlain, A. Clausell, and M.V. Norgard. 1988. Identification and Localization of Integral Membrane Proteins of Virulent Treponema pallidum subsp. pallidum by Phase Partitioning with the Nonionic Detergent Triton X-114. Infect. Immun. 56:490-498.
4. E.J. Hansen, F.R. Gonzales, N.R. Chamberlain, M.V. Norgard, E.E. Miller, L.D. Cope, S.E. Pelzel, B. Gaddy, and A. Clausell. 1988. Cloning of the Gene Encoding the Major Outer Membrane Protein of Haemophilus influenzae type b. Infect. Immun. 56 2709-2716.
5. P.L. Hsu, N.R. Chamberlain, K. Orth, C. Moomaw, L.Q. Zhang, C. Slaughter, J.D. Radolf, S. Sell, and M.V. Norgard. 1989. Sequence Analysis of the 47-Kilodalton Major Integral Membrane Immunogen of Treponema pallidum. Infect. Immun. 57:196-203.
6. N.R. Chamberlain, M.E. Brandt, A.L. Erwin, J.D. Radolf, and M.V. Norgard. 1989. Major Integral Membrane Protein Immunogens of Treponema pallidum are Proteoplipids. Infect. Immun. 57: 2872-2877.
7. N.R. Chamberlain, L. GeOgny, C. Slaughter, J.D., Radolf, and M.V. Norgard. 1989. Acylation of the 47-Kilodalton Major Membrane Immunogen of Treponema pallidum Determines its Hydrophobicity. Infect. Immun. 57: 2878-2885.
8. B.K. Purcell, N.R. Chamberlain, M.S. Goldberg, L.P. Andrews, E.J. Robinson, M.V. Norgard, and J.D. Radolf. 1989. Molecular Cloning and Characterization of the 15-Kilodalton Major Immunogen of Treponema pallidum. Infect. Immun. 57: 3708-3714.
9. N.R. Chamberlain, B.G. Mehrtens, Z. Xiong, F.A. Kapral, J.L. Boardman, and J.I. Rearick. 1991. Correlation of Carotenoid Production, Decreased Membrane Fluidity, and Resistance to Oleic Acid Killing in Staphylococcus aureus 18Z. Infect. Immun. 59:4332-4337.
10. N.R. Chamberlain. 1992. Another Easy Method of Extruding Polyacrylamide Gels from Isoelectric Focusing Tubes of 1.5-mm Inside Diameter. BioTechniques. 13:532
11. Z. Xiong, S.Ge, N.R. Chamberlain and F.A. Kapral. 1993. Growth Cycle Induced Changes in Staphylococcus aureus Sensitivity to Abscess Bactericidal Lipids. J. Med. Micro. 39:58-63
12. N.R. Chamberlain and B. Imanoel. 1996. Genetic Regulation of Fatty Acid Modifying Enzyme from Staphylococcus aureus. Journal of Medical Microbiology. 44:125-129
13. N.R. Chamberlain and S.A. Brueggemann. 1997. Characterization and Expression of Fatty-Acid Modifying Enzyme (FAME) as Produced by Staphylococcus epidermidis. J. Med. Micro. 46:693-697.
14. R.W. Baer and N.R. Chamberlain. 1998. Environmental factors promoting the effective use of a computer-assisted clinical case for second-year osteopathic medical students. Journal of the American Osteopathic Association. 98:380-385.
15. N.R. Chamberlain. 1999. Identification and partial characterisation of an extracellular activator of fatty-acid modifying enzyme (FAME) expression in Staphylococcus epidermidis. J. Med. Micro. 48:245-252.
16. N.R. Chamberlain and H.A. Yates, 2000. Use of a Computer Assisted Clinical Case (CACC)-SOAP Note Exercise to Assess Students' Application of Osteopathic Manipulative Principles. JAOA.100:437-440.
17. M.K. Stuart and N.R. Chamberlain. 2003. Monoclonal Antibodies to Elongation Factor-1alpha Inhibit In Vitro Translation in Lysates of Sf21 Cells. Arch. Insect Biochem and Physiol. 52(1):17-34.
18. N.R. Chamberlain and H.A. Yates. 2003. A prospective study of osteopathic medical students' attitudes toward use of osteopathic manipulative treatment in caring for patients. JAOA. Oct;103(10):470-8.
19. Singh VK, Utaida S, Jackson LS, Jayaswal RK, Wilkinson BJ, Chamberlain NR. 2007. Role for dnaK locus in tolerance of multiple stresses in Staphylococcus aureus. Microbiology. 153 (9): 3163-3174.
20. Singh VK, Giotis ES, Chamberlain NR, Stuart MK, and Wilkinson BJ. 2008. Insertional Inactivation of Branched-Chain a-Keto Acid Dehydrogenase (BKD) in Staphylococcus aureus Leads to Decreased Branched-Chain Membrane Fatty Acids Content and Increased Susceptibility to Certain Stresses. Applied and Environmental Microbiology. 74:5882-5890.
BOOKS:
1. Chamberlain, NR. The Big Picture Medical Microbiology. 2009. McGraw-Hill Companies Inc., New York. ISBN: 978-0-07-147661-4
BOOK REVIEWS:
1. "Cellular and Molecular Mechanisms or Toxin Action- Pore-Forming Peptides and Protein Toxins". 1st edition, Edited by G. Menestra, M.D. Serra, and P. Lararovici. 2004. International Journal of Toxicology. 23(2):146-147.
ONLINE WEBSITES:
Medical Microbiology: Neal Chamberlain’s Look at the Microbial World. 1996-2009. http://www.kcom.edu/faculty/chamberlain/ and http://www.geocities.com/medmicro.geo/
ONLINE PEER-REVIEWED PUBLICATIONS:
1. Chamberlain NR.: 2000. Gram Stain of Bacillus subtilis. Visual Resources: MicrobeLibrary.org. http://www.microbelibrary.org/asmonly/Details.asp?id=369
2. Chamberlain NR.: 2000. Mycobacterium phlei digital images. Visual Resources: MicrobeLibrary.org. http://www.microbelibrary.org/asmonly/Details.asp?id=370
3. Chamberlain NR.: 2000. Bacitracin Sensitivity Using Group A and B Beta-Hemolytic Streptococci. Visual Resources: MicrobeLibrary.org. http://www.microbelibrary.org/asmonly/Details.asp?id=605
4. Chamberlain NR: 2001. Growth Inhibition of Streptococcus pyogenes by Bacitracin. Visual Resources: MicrobeLibrary.org. http://www.microbelibrary.org/asmonly/Details.asp?id=741
5. Chamberlain NR: 2001. Spore Stain of Bacillus subtilis. Visual Resources: MicrobeLibrary.org. http://www.microbelibrary.org/asmonly/Details.asp?id=760
6. Chamberlain, NR. 2001. Lactose Fermentation on MacConkey Agar Plates. Visual Resources: MicrobeLibrary.org.
http://www.microbelibrary.org/asmonly/Details.asp?id=602
7. Chamberlain, NR. 2001. Catalase Test. Visual Resources: MicrobeLibrary.org. http://www.microbelibrary.org/asmonly/Details.asp?id=710
8. Chamberlain NR: 2002. Reactions in TSI Agar Slants. Visual Resources: MicrobeLibrary.org. http://www.microbelibrary.org/asmonly/Details.asp?id=780
9. Chamberlain NR: 2004. Transmission Cycles of Plague. Visual Resources: MicrobeLibrary.org. http://www.microbelibrary.org/asmonly/Details.asp?id=1732
ABSTRACTS:
1. Delta Toxin Produced in Murine Intraperitoneal Abscesses by Staphylococcus aureus. N.R. Chamberlain, and F.A. Kapral. American Society for Microbiology Local Ohio Meeting, Dayton, Ohio, November, 1984.
2. Delta Toxin Produced by Staphylococcus aureus in Murine Intraperitoneal Abscesses. N.R Chamberlain, and F.A. Kapral. Abstracts of the Annual Meeting of the American Society for Microbiology, Las Vegas, Nevada, March, 1985.
3. Enhanced Expression and Initial Chemical Characterization of the Recombinant DNA-derived 47-kDa Major Surface Immunogen of Treponema pallidum. N.R. Chamberlain, J.D. Radolf, and M.V. Norgard. Abstracts of the Annual Meeting of the American Society for Microbiology, Washington, D.C., 1987.
4. Cloning and Expression of the Gene Encoding the 39-Kilodalton Major Outer Membrane Protein of Haemophilus influenzae type b. E.J. Hansen, F.R. Gonzales, L.D. Cope, N.R. Chamberlain, M.V. Norgard, E.E. Miller, S.E. Pelzel, and B. Gaddy. Abstracts of the Annual Meeting of the American Society for Microbiology, Miami Beach, Florida, 1988.
5. Major Integral Membrane Protein Immunogens of Treponema pallidum are Lipoproteins. N.R. Chamberlain, M.E. Brandt, A.L. Erwin, J.D. Radolf, and M.V. Norgard. Abstracts of the Annual Meeting of the American Society for Microbiology, New Orleans, Louisiana, 1989.
6. Survival of Staphylococcus aureus Treated with Oleic Acid is Related to Stabilization of the Bacterial Membrane by Staphylococcal Carotenoids. N.R. Chamberlain, J. Rearick, B. Mehrtens, and J. Boardman. Abstracts of the Annual Meeting of the American Society for Microbiology, Dallas, Texas, 1991.
7. Survival of Staphylococcus aureus Treated with Oleic Acid is Related to Stabilization of the Bacterial Membrane by Staphylococcal Carotenoids. N.R. Chamberlain, J. Rearick, B. Mehrtens, and J. Boardman. Staphylococcal Diseases. Gordon Conferences; August 5-9; Newport, Rhode Island, 1991.
8. Survival of Staphylococcal aureus Treated With Oleic Acid is Related to Stabilization of the Bacterial Membrane by Staphylococcal Carotenoids. N.R. Chamberlain, J. Rearick, B. Mehrtens, and J. Boardman. 35th Annual Research Conference at the National American Osteopathic Association Meeting, November 3-7, 1991, in New Orleans, Louisiana. Poster.
9. Partial Cloning of the Carotenoid Synthesis Pathway From Staphylococcus aureus. J. Boardman and N.R. Chamberlain. Missouri Branch of the American Soci Microbiology, April 3-4, 1992, Columbia, Missouri. 10 min. talk.
10. Growth Cycle Induced Changes in Staphylococcus aureus Sensitivity to Abscess Bactericidal Lipids. Z. Xiong, S. Ge., N.R. Chamberlain and F.A. Kapral. Eric K. Fernstrom Symposium. Molecular Pathogenesis of Surgical Infections. June 21-25, 1992. Lund, Sweden.
11. Partial Cloning of the Carotenoid Synthesis Pathway From S. aureus. N.R. Chamberlain, 36th Annual Research Conference at the National American Osteopathic Association Meeting. November 1-5, 1992, San Diego, California.
12. Characterization, Partial Purification and Production of Monoclonal Antibodies to Fatty Acid Modifying Enzyme From Staphylococcus aureus 18Z. N.R. Chamberlain and M. Stuart. Submitted to American Society of Microbiology. May 16-20, 1993, The General Meeting in Atlanta, Georgia.
13. Partial Purification, Characterization, and Genetic Regulation of Fatty Acid Modifying Enzyme from Staphylococcus aureus. N.R. Chamberlain, Area Research Enhancement Award Workshop and Conference. April 8-9, 1995, Indianapolis, Indiana.
14. Production and Regulation of Fatty Acid Modifying Enzyme as Produced by Staphylococcus epidermidis. N. R. Chamberlain, 96th American Society of Microbiology General Meeting, May 19-23, 1996, New Orleans, Louisiana.
15. Identification and Characterization of an Activator of FAME Expression in Staphylococcus epidermidis. N.R. Chamberlain and K.D. Williams. 97th American Society of Microbiology General Meeting, May 4-8, 1997, Miami Beach, Florida.
16. Use of World Wide Web Technologies to Develop a Computer-Assisted Clinical Case for Second Year Medical Students. N.R. Chamberlain and R.W. Baer. 98th American Society of Microbiology General Meeting, May 17-21, 1998, Atlanta Georgia.
17. Assessment of KCOM Student's Clinical Skills with a Computer-Assisted Clinical Case (CACC)-SOAP Note Exercise.
N.R. Chamberlain. Central Group of Educational Affairs, Association of American Medical Colleges, Spring Meeting, March 25-28, 1999, Kansas City, Missouri.
18. Activator Protein and Cross-strain Communication in Staphylococcus epidermidis. J.I. Smart and N.R. Chamberlain.Joint Annual Meeting of the Missouri Branch of the American Society for Microbiology and Midwest Microbiology Educators
Conference. April 9-10, 1999, St. Louis, Missouri.
19. Activator Protein and Cross-strain Communication in Staphylococcus epidermidis. The General Meeting of the American Society for Microbiology 100th General meeting in Los Angeles, CA, May 21-25, 2000. J.I. Smart and N.R. Chamberlain.
20. Identification and Partial Characterization of Factors that Inhibit Adherence of Staphylococcus epidermidis to Polystyrene. N.R. Chamberlain. The General Meeting of the American Society for Microbiology 100th General meeting in Los Angeles, CA, May 21-25, 2000.
21. Use of "The Golden Stethoscope Contest" to promote Students' Integration of Medical Knowledge during and Infectious Disease Course. N.R. Chamberlain. 7th Annual MSUCOM SCS Kirksville COM and Ohio University COM in East Lansing, MI, May 22-23, 2001.
22. Production of Monoclonal Antibodies to Elongation Factor-1a from Spodoptera frugiperda. M.K. Stuart and N.R. Chamberlain. Rocky Mountain Conference of Entomologists, August 5-9, 2001, Woodland Park, Colorado.
23. Monoclonal antibodies to elongation factor-1a inhibit in vitro protein translation in lysates of Sf21 cells. Stuart and N.R. Chamberlain. The Entomological Society of America 2001 Annual Meeting. December 10, 2001. San Diego, CA.M.K.
24. Use of "The Golden Stethoscope Contest" to promote and evaluate Students' Integration of Medical Knowledge. N.R. Chamberlain. The General Meeting of the American Society for Microbiology 102th General meeting in Salt Lake City, UT, May 19-23, 2002.
25. Immunological inactivation of elongation factor-1 alpha in Sf21 cell lysates. M.K. Stuart and N.R. Chamberlain. ISMIS 2002. Abstracts of the Fourth International Symposium on Molecular Insect Science. 70pp. Journal of Insect Science, 2:17, Available online: http://www.insectscience.org/2.17
26. Purification and Characterization of a Bioactive Pheromone from Staphylococcus epidermidis. N.R.Chamberlain, J.I. Smart, T.P. Geisbuhler. The General Meeting of the American Society for Microbiology, 104th General meeting in New Orleans, LA. May 23-27, 2004.
27. Harpenau CM, Inoue A, Johnson JC, Chamberlain NR, Jadoon-Khamash E, Noll DR: The Immediate Effects of the Splenic Pump Technique on Blood Cell Counts in Normal Adults. Journal of the American Osteopathic Association 106(8):474, 2006.
28. Inoue A, Harpenau CM, Chamberlain NR, Johnson JC, Jadoon-Khamash E, Noll DR: The Immediate Effects of the Splenic Pump on Serum Levels of C-reactive Protein in Normal Adults Journal of the American Osteopathic Association 106(8):474-475, 2006.
29. Neil J. Sargentini, PhD, Julia E. McNabb, DO, FAAFP, Dena Higbee, BA, Melissa K. Stuart, PhD, Neal R. Chamberlain, PhD, Michael D. Lockwood, DO, FCA, Using Standardized Patient Encounters to Improve Basic Science Understanding and Integrate Professional Behavior and Clinical Skills Assessment within Two Medical School Basic Science Courses; Central Group on Educational Affairs; Association of American Medical Colleges; Spring Conference 2007; Indianapolis, Indiana; March 22-24, 2007.
30. V. K. Singh, S. Utaida, L. S. Jackson, R. K. Jayaswal, B. J. Wilkinson, N. R. Chamberlain. 2007. Role for DnaK, a Major Heat Shock Protein, in Tolerance of Multiple Stresses in Staphylococcus aureus. The General Meeting of the American Society for Microbiology, 107th General meeting in Toronto, Canada. May 21-25, 2007.
31. V Singh, D Hattangady, E Giotis, N Chamberlain, M Stuart, and B Wilkinson. Insertional Inactivation of Branched-Chain a-Keto Acid Dehydrogenase (BKD) in Staphylococcus aureus Leads to Decreased Branched-Chain Membrane Fatty Acids Content and Increased Susceptibility to Certain Stresses. International Symposium on Staphylococci and Staphylococcal Diseases, September 7-10, 2008, Cairns, Australia.
32. M. K. Stuart, N. R. Chamberlain, V. K. Singh, N. J. Sargentini. Microbiology for Medical Students: A Case Presentations Model. The General Meeting of the American Society for Microbiology, 109th General meeting in Philadelphia, PA. May 17-21, 2009.
GRANTS:
1. Development of a Staphylococcus aureus Strain Pair Useful In An Antibacterial Screen of Membrane Damaging Agents. Funding Agency: Eli Lilly, Greenfield, Indiana. Total Amount of Grant: $23,000; 9/91 to 8/92.
2. Molecular Analysis of Staphylococcal Virulence Factors. Funding Agency: Charles and Jennie Fermaturo Foundation. Total Amount: $3,500; 7/1/90 - 7/1/93
3. Purification of Fatty Acid Modifying Enzyme From S. aureus. Funding Agency: Warner Fund.
Total Amount: $3,800; 6/30/91-6/30/93
4. Role of An Acyltransferase In Staphylococcal Infections. Funding Agency: National Institutes of Health. Total Amount: $92,969.44; 7/1/93-6/30/97
5. Development of a Synthetic Peptide-Based Serological Test for Syphilis. Funding Agency: Kirksville College of Osteopathic Medicine, Strategic Research Award.
Total Amount: $12,000; 7/15/98-7/30/99.
6. Web-based dissemination of KCOM's Curriculum to KCOM Students. KOAA/KCOM education program fund grant, Total Amount: $5,000; 7/1/99-6/30/00.
7. Creation of a Three-Dimensional Computer-Assisted Clinical Patient. Auxiliary to the Missouri Association of Osteopathic Physicians and Surgeons, Total Amount: $2,500; 5/30/99-4/30/00.
8. Characterization of Staphylococcal Adherence Inhibitors. Funding Agency: Warner Fund. Total Amount: $3,000; 9/1/00- 6/30/04.
9. Effect of Total Tooth Extraction in Patients with Severe Periodontal Disease on Serum C-Reactive Protein Levels. Funding Agency: Prodental. Total Amount: $17,435; 5/17/04-4/30/05.
10. Purification and Characterization of Novel Pheromones from Staphylococcus epidermidis. Funding Agency: Warner Fund. Total Amount: $4,000; 7/1/04-6/30/06.
11. Pheromone Diversity in Staphylococcus, KCOM Biomedical Sciences Program, Total Amount: $5,000; 9/1/04-8/31/06.
12. The Immediate Effects of the Splenic Pump in Normal Adults, KCOM Strategic Research Initiative, Total Amount: $27,605; 8/01/05-7/31/06.
13. The Persistence Phenomenon in Staphylococcus epidermidis. KCOM Biomedical Sciences Program, Total Amount: $5,000; 4/06-8/08
14. Genetic Regulation of Persister Formation in Staphylococcus aureus. Warner/Fermaturo and ATSU Board of Trustees Research Funds; $4,000; 06/01/08-05/31/10.
15. Moving from Passive to Active Learning: Use of an Audience Response System. KOAA/KCOM Education Program Fund; $5,600; 7/1/08-6/30/09.
16. Osteopathic Manipulative Treatment: Assessing Medical Student Beliefs About OMT Before Entering Medicine School to Their Utilization of OMT in Their Clinical Practice; AACOM Medical Education Research Mini-Grant, $5,000, 03/01/09-02/28/10.
17. Persistence Phenomenon of Staphylococcus epidermidis Following Antibiotic Treatment. KCOM Biomedical Sciences Program, Total Amount: $5,000; 4/09-6/10
18. Osteopathic Manipulative Treatment: Assessment of KCOM Medical Student Beliefs About OMT Before Entering Medical School and After One Year at KCOM. KOAA/KCOM Education Program Fund; $2,000; 6/1/09-6/30/10.
TEACHING ACTIVITIES
Teaching at ATSU
Lectured in Medical Microbiology course (bacteriology, parasitology) 1989-1993.
Lectured in Immunology course 1989-1992.
Lectured in Infectious Diseases (respiratory, gastrointestinal, bone and joint, cardiovascular, genitourinary (includes STD/STI), septic shock, hematopoietic/lymphoreticular systems) course director from 2000-2003) 1990 to present.
Taught all the labs in Medical Microbiology, Immunology, and Infectious Diseases 1989 to present.
Lectured in Oral Communications course (graduate course; course director) 2002 to present.
Teaching at other Institutions
Lectured at the Kansas City University of Medicine and Biosciences on various medical microbiology topics to their medical students from 2003 to 2006.
Lectured at the Des Moines University on various medical microbiology topics to their medical students in 2005 and 2006.
TEACHING AWARDS
1. The A.T. Still Staff Award for Excellence in Teaching, 1996-1997.
2. The Max T. Gutensohn Excellence in Teaching Award, 1996-1997.
3. The Alpha Phi Omega 1999 Golden “P” Award for Teaching.
4. The Max T. Gutensohn Award for Outstanding Teaching, 2003
5. Governor's Award for Excellence in Teaching, Presented by the Governor of the state of Missouri on December 4, 2003.
6. The Max T. Gutensohn Award for Outstanding Teaching, 2005
7. The Max T. Gutensohn Award for Outstanding Teaching, 2007
8. The Basic Sciences Speaker at the Class of 2010's "The Last Lecture ceremony", June 27th, 2008.
9. Inducted as a Fellow into the inaugural class of the National Academy of Osteopathic Medical Educators (NAOME) April 17, 2009. The academy was created by the American Association of Colleges of Osteopathic Medicine (AACOM) in 2008.
10. The Max T. Gutensohn Award for Outstanding Teaching, 2009
11. Leonard Tow Humanism in Medicine Award presented by the Arnold P. Gold Foundation. The graduating class of 2009 selected me as a faculty member who displays humanism in medicine through teaching. May 15, 2009.
12. The Basic Sciences Speaker at the Class of 2011's "The Last Lecture ceremony", May 21th, 2009.
KCOM COMMITTEE ASSIGNMENTS:
1. Curriculum Committee; September 1, 1990 to June 30, 1993 and Sept. 2000 to Feb. 2003.
2. Executive Council of Faculty; September 1, 1991 to December 1994.
3. KCOM Fund for the Improvement of Post-Secondary Education (FIPSE); Sept. 1, 1991 to December 31, 1992.
4. Student Well-Being Task Force; April 1, 1992 to Dec.1993.
5. Instructional Design Committee; Sept. 1997 to August 1998.
6. Student Financial Assistance Committee; Sept. 1997 to Sept 2001.
7. PDA document Ad Hoc subcommittee of the Computer Committee; Dec. 2001- March 2002.
8. New Books Ad Hoc subcommittee of the Library; June 1999 to 2005.
9. Library Committee; December 1999 to 2004.
10. Computer Committee; September 2000 to 2004.
11. Interviewing prospective students for KCOM; Sept. 1989 to present.
12. Faculty Senate; 2003 to present.
13. The Scholarship of Teaching Task Force; 2006.
14. Pre-Screening Committee for admission of prospective medical students; 2007 to 2009.
15. Subcommittee to submit report on Criterion 5 (Community Relations) to the North Central Association Commission on Accreditation and School Improvement for accreditation; Jan 2008- March 2009.
16. Committee to aid in the hiring of a Chairperson in the anatomy department at KCOM; 2008-2009.
17. University Assessment Committee for ATSU; 2009 to present.
18. Elected by KCOM faculty to serve as a representative to the ATSU University Faculty Senate; 2009.
OFF CAMPUS COMMITTEE ASSIGNMENTS:
1. Student Membership; American Society for Microbiology, May 1994 to 2006.
2. Level 1 item review committee for the National Board of Osteopathic Examiners. Oct. 1999 to 2007.
OFF CAMPUS SEMINARS:
1. Staphylocidal Membrane Active Agents Produced During Infection. Antimicrobial Agents of the Future? June 1992; Eli Lilly in Greenfield, Indiana.
2. Bacterial Pathogenesis: How Staph Makes us Sick. Biology Seminar Series. April 19, 1995; Northeast Missouri State University, Kirksville, Missouri.
3. Bacterial Communications. September 21, 1998; Truman State University, Tri-Beta Honorary Science Club, Kirksville, Missouri.
4. Microbiology of Wounds. 102nd Missouri Osteopathic Annual Convention, May 6, 2000 during a wound care symposium.
5. Biological Terrorism seminar at a continuing medical education (CME) program at KCOM titled, "Bioterrorism: Are You Prepared?" Nov. 27, 2001.
ATSU/KCOM STUDENTS TRAINED IN MY LABORATORY:
1. Frank Bowman (D.O. Student) - Summer 1990
2. Jerry Burbee (D.O. Student) - Summer 1991
3. Gary Vickers (D.O. Student) - Summer 1992
4. Babak Imanoel (D.O. Student) - Spring 1993 - Fall 1994
TSU STUDENTS TRAINED IN MY LABORATORY:
1. Noel Wood - September 1989 to May 1990
2. Brad Mehrtens - September 1990 to May 1991
3. Jeff Fowler - September 1991 to June 1992
4. Mary Rose Twohig - September 1995 to May 1996
5. Kimberly Williams - September 1995 to August 1996
6. Jennifer Smart- January 1999 to May 1999
ATSU GRADUATE STUDENTS TRAINED IN MY LABORATORY:
1. Julie Shapiro (M.S./D.O. Student) - Thesis: The Persistence Phenomenon in Staphylococcus epidermidis RP62A. Degree: Masters Biomedical Sciences. July 2005 to June 2007
2. Andi Lynch (M.S./D.O. Student) - Thesis: Characterization of an Extracellular Activator of Fatty Acid Modifying Enzyme (FAME) in Staphylococcus epidermidis RP62A. Degree: Masters Biomedical Sciences. February 2004 to June 2008.
3. Valerie Nguyen (M.S. Student) - Thesis: Persistence Phenomenon of Staphylococcus epidermidis Following Antibiotic Treatment. September 2008- ?
Truman State University GRADUATE STUDENTS TRAINED IN MY LABORATORY:
1. Steve Brueggemann- Thesis: Characterization and Regulation of Fatty-Acid Modifying Enzyme (FAME) as Produced by Staphylococcus epidermidis. Degree: M.S. September 1993 to May 1996.
Last revised 5/14/09